Literature DB >> 1361123

Effects of nipradilol on the microvascular tone of rat mesentery: comparison with other beta-blockers and vasodilators.

H Araki1, M Itoh, K Nishi.   

Abstract

The effects of nipradilol, a nonselective beta-blocker with vasodilator activities, on the diameter of arterioles and venules were examined in rat mesentery in vivo and were compared with those of propranolol, atenolol, labetalol, nifedipine and nitroglycerin. Topical application of nipradilol (10(-7) M and 10(-6) M) dilated the arterioles significantly to 109 +/- 2% and 112 +/- 2% of control, respectively (mean +/- S.E.; n = 9; p < 0.01), without changes in blood pressure and pulse rate. The dilator effect was comparable to that of nifedipine and nitroglycerin. Propranolol constricted the arterioles (to 86 +/- 3% at 10(-7) M; n = 9; p < 0.01), but atenolol and labetalol had no significant effects. Nitroglycerin dilated venules significantly (to 108 +/- 2% at 10(-7) M; n = 6; p < 0.01) but other drugs showed no significant effects on the tone of venules. Unlike the other beta-blockers used in this study, nipradilol has dilator effects on arterioles as have nifedipine and nitroglycerin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361123

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  3 in total

Review 1.  Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Authors:  Chihiro Mayama; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2013-01-16       Impact factor: 2.447

2.  Nitric oxide mediated venodilator effects of nebivolol.

Authors:  A J Bowman; C P Chen; G A Ford
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

3.  Intracellular Ca2+ silences L-type Ca2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers.

Authors:  Keshari M Thakali; Sujay V Kharade; Swapnil K Sonkusare; Sung W Rhee; Joseph R Stimers; Nancy J Rusch
Journal:  Circ Res       Date:  2009-12-31       Impact factor: 17.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.